Applied Molecular Transport (AMT) is a privately held venture-backed, clinical-stage biopharmaceutical company that is applying its proprietary bioengineering technology platforms to create transformative oral biological therapies for patients with severe autoimmune, inflammatory, liver and metabolic diseases. Learn More
Privileged Access to GI Immunology and Convergent Pathways
Changing the Paradigm for Biologics
Applied Molecular Transport Appoints Veteran Biopharmaceutical Executive, Liz Bhatt, to Role as Chief Business and Strategy Officer | Learn More
No events scheduled at this time.